Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility, primarily because it disrupts ovulation. Without the regular release of a mature egg, conception can’t happen on its own timeline. But PCOS affects fertility in several ways beyond just skipped periods, including changes to egg quality, the uterine lining, and early pregnancy outcomes. The good news: most people with PCOS can still get pregnant, often with relatively straightforward interventions.
Why Ovulation Stops Working
In a typical cycle, your brain sends signals that trigger two key hormones: luteinizing hormone (LH) and follicle-stimulating hormone (FSH). FSH does what its name suggests, helping a follicle in your ovary grow until it’s mature enough to release an egg. LH then surges to trigger that release. In PCOS, this system gets thrown off at multiple points.
The core problem is that your brain’s hormone-signaling center fires too rapidly, pumping out GnRH (the master signal) in quick pulses. This produces too much LH relative to FSH. The excess LH drives your ovaries’ outer cells to churn out androgens (often called “male hormones,” though everyone makes them). Meanwhile, FSH stays too low to properly nurture a follicle to full maturity. Follicles start growing but stall at a small size, lining up along the edge of the ovary. That’s the “polycystic” appearance on ultrasound: not true cysts, but a collection of follicles that never finished developing.
Insulin resistance makes this worse. About 70% of people with PCOS have some degree of insulin resistance, meaning their bodies produce extra insulin to compensate. The ovaries remain highly sensitive to insulin even when other tissues stop responding well, so all that extra insulin pushes androgen production even higher. Elevated insulin also appears to dampen the signaling molecules that keep the whole hormone cascade in check, creating a self-reinforcing cycle.
How Excess Androgens Damage Egg Quality
The fertility impact of PCOS goes deeper than just preventing ovulation. Prolonged exposure to high androgen levels changes how follicles develop from the very earliest stages. Research in animal models of PCOS shows that while early-stage follicles may look healthy, follicles that reach later stages of growth have significantly reduced survival rates and poorer overall health. Even more concerning, these defects persist after the excess androgens are removed, suggesting the damage accumulates over time.
Eggs from PCOS-affected ovaries also show higher levels of oxidative stress, which is essentially cellular damage from unstable molecules. This translates into real consequences: slower and less reliable embryo development after fertilization. Androgens also appear to interfere with the communication channels between the egg and its surrounding support cells, disrupting the teamwork needed for a healthy, mature egg.
Ironically, people with PCOS often have a high number of eggs. A blood marker called AMH, which reflects your egg supply, tends to run higher in PCOS. But a large reserve doesn’t equal a good one. Having many follicles that can’t properly mature is a bit like having a full pantry of unripe fruit.
Higher Miscarriage Risk
Fertility challenges with PCOS don’t end at conception. Even when a genetically normal embryo implants, the miscarriage rate is higher. In one study of women who received single embryos that had been tested and confirmed chromosomally normal, those with PCOS had an early miscarriage rate of about 19% compared to 12% in women without the condition. That’s roughly a 65% increase in odds after accounting for other variables.
Since the embryos in that study were already confirmed to have normal chromosomes, the higher loss rate points to problems with the uterine lining itself. The same hormonal disruptions that prevent ovulation, chronically elevated androgens and insulin, also affect how the endometrium prepares for and sustains a pregnancy.
Getting a Diagnosis
PCOS is diagnosed when you have at least two of three features: irregular or absent periods (a sign of ovulation problems), elevated androgens (detected through blood tests or symptoms like acne and excess hair growth), and polycystic-appearing ovaries on ultrasound. A blood test measuring AMH can now be used as an alternative to ultrasound. If you have both irregular cycles and signs of high androgens, the diagnosis can be made without imaging or AMH testing at all.
For teenagers, the criteria are stricter. Both irregular cycles and elevated androgens must be present, because polycystic-looking ovaries and irregular periods are common in adolescence and don’t necessarily indicate PCOS.
Weight Loss and Ovulation Recovery
For people with PCOS who carry extra weight, losing even a modest amount can meaningfully restore fertility. Clinical data shows that each 1% reduction in body weight is associated with about a 5.6% increase in the odds of recovering regular ovulation. A weight loss of 5 to 10% is the range most commonly associated with improvements in both metabolic markers and reproductive function.
That means if you weigh 200 pounds, losing 10 to 20 pounds could be enough to restart ovulation. This works because less body fat reduces insulin levels, which in turn lowers androgen production, which allows follicles to mature normally again. Weight loss alone won’t work for everyone, and it’s not relevant for people with PCOS who are at a normal weight, but when applicable it’s one of the most effective first steps.
Medications That Trigger Ovulation
When lifestyle changes aren’t enough, ovulation induction is the standard first-line treatment. International guidelines now recommend letrozole as the preferred starting medication, replacing the older drug clomiphene. Both work by nudging the brain to produce more FSH so follicles can finish maturing, but they do so through different mechanisms, and letrozole has shown better outcomes in head-to-head trials.
In a large study tracking women with PCOS through standardized treatment protocols, 37% achieved a pregnancy leading to a term birth within the first year. That’s a meaningful success rate, particularly considering it includes only pregnancies that reached full term. Many more achieved pregnancies that ended earlier or continued treatment beyond the first year.
For those who don’t respond to oral medications, the next steps typically involve injectable hormones or IVF. But most people with PCOS won’t need to go that far. Because the underlying egg supply is usually adequate or even high, the main challenge is coaxing an egg to release, and that’s often achievable with medication alone.
Supplements and Insulin-Sensitizing Treatments
Because insulin resistance is such a central driver of PCOS, treatments that improve insulin sensitivity can also improve fertility. Metformin, a medication originally developed for type 2 diabetes, is commonly used alongside or before ovulation-inducing drugs. Myo-inositol, an over-the-counter supplement, has gained popularity as a more accessible option that works through similar pathways.
In a clinical trial comparing the two in women undergoing assisted reproduction, metformin produced a 38% pregnancy rate and a 28% live birth rate, while myo-inositol achieved 32% and 22% respectively. A group using only lifestyle modifications saw 25% and 15%. Both metformin and inositol outperformed lifestyle changes alone, with metformin showing a slight edge. That said, inositol has fewer side effects (metformin commonly causes digestive issues), which is why many people try it first or use it alongside other treatments.
The Bigger Picture
PCOS is the most treatable common cause of infertility. The condition creates real barriers, from blocked ovulation to impaired egg quality to a less receptive uterine lining, but each of these can be addressed. Most people with PCOS who pursue treatment will eventually conceive, though it may take longer and require more medical support than they initially expected. The key is understanding that PCOS affects multiple steps in the reproductive process, so the most effective approach often combines strategies: reducing insulin resistance through weight management or medication, triggering ovulation with targeted drugs, and monitoring early pregnancy more closely.